EFDID: 507608EFD: View Filing

Issuer: IMMUNIC, INC. (0001280776) - D

Accession: 0001193805-24-000065 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001280776
  • Entity Name:
    IMMUNIC, INC.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Over 5 years ago
  • Address:
    1200 AVENUE OF THE AMERICAS, SUITE 200
    NEW YORK, X1 10036
  • Persons:
    Related Persons 12
    Daniel Vitt
    Executive Officer, Director
    Duane Nash
    Director 
    Executive chairman of board of directors
    Tamar Howson
    Director
    Barclay Phillips
    Director
    Jorg Neermann
    Director
    Richard Rudick
    Director
    Andreas Muehler
    Executive Officer
    Patrick Walsh
    Executive Officer
    Maria Tornsen
    Director
    Hella Kohlhof
    Executive Officer 
    Chief Scientific Officer
    Glenn Whaley
    Executive Officer
    Inderpal Singh
    Executive Officer 
    General Counsel
EDGAR: Offering Information
  • Accession Date:
    01/19/2024
  • First Sale Date:
    01/04/2024
  • Offering Amount:
    $240,000,000
  • Amount Sold:
    $80,000,016
  • Amount Remaining:
    $159,999,984
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
  • Sales Clarification:
    Offering to be sold in 3 tranches of $80,000,000 each, subject to specified conditions. Third tranche permits funding on a "cashless" or net exercise basis.
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:CA, CT, MA, NY, TX
Inactive:CO, IL
EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
None None Leerink Partners LLC 39011 CA, CO, CT, IL, MA, NY, TX
None None Ladenburg Thalmann & Co. Inc. 505 CA, CO, CT, IL, MA, NY, TX
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
IMMUNIC, INC./s/ Glenn WhaleyGlenn WhaleyChief Financial Officer2024-01-19